Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.

[1]  D. Wofsy.  Regulation of immunity by anti-T-cell antibodies. , 1990, The Western journal of medicine.

[2]  H. Stockinger,et al.  Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. , 1989, Journal of autoimmunity.

[3]  H. Weiner,et al.  Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. , 1988, Journal of immunology.

[4]  J. Strominger,et al.  Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.

[5]  C. Janeway,et al.  Evidence for a physical association of CD4 and the CD3: α : β T-cell receptor , 1987, Nature.

[6]  R. Steinman,et al.  Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes , 1987, Journal of Experimental Medicine.

[7]  T. Hunkapiller,et al.  Isolation and sequence of L3T4 complementary DNA clones: expression in T cells and brain. , 1986, Science.

[8]  W. Seaman,et al.  Induction of immune tolerance by administration of monoclonal antibody to L3T4. , 1986, Journal of immunology.

[9]  H. Waldmann,et al.  Induction of tolerance by monoclonal antibody therapy , 1986, Nature.

[10]  L. Chess,et al.  Perturbation of the T4 molecule transmits a negative signal to T cells , 1985, The Journal of experimental medicine.

[11]  E. Shevach,et al.  Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells. , 1985, Journal of immunology.

[12]  R. Germain,et al.  Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression. , 1985, Journal of immunology.

[13]  S. Wahl,et al.  NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. , 1984, Annals of internal medicine.

[14]  S. Swain.  T Cell Subsets and the Recognition of MHC Class , 1983, Immunological reviews.

[15]  W. Pichler,et al.  Activation of T cells by cross‐linking an anti‐CD3 antibody with a second anti‐T cell antibody: mechanism and subset‐specific activation , 1987, European journal of immunology.

[16]  C. Janeway,et al.  The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal. , 1986, The Journal of molecular and cellular immunology : JMCI.